SEC 13F Intelligence

EGRXEAGLE PHARMACEUTICALS IN

CUSIP 269796108 · Yahoo Finance ↗ · Google Finance ↗

Eagle Pharmaceuticals In (EGRX) has 2 institutional holders in Filings Flow’s 13F database, together reporting 12.3K shares worth $4,212 as of Q1 2026.

Institutional Holders
2
Q1 2026
Reported Value
$4,212
Ticker
EGRX
Quarters Tracked
9

Ownership Trend

Institutional holders
Q4 ’18: 155Q4 ’18Q1 ’19: 154Q2 ’19: 152Q2 ’19Q3 ’19: 155Q2 ’21: 129Q2 ’21Q4 ’21: 145Q4 ’22: 137Q4 ’22Q4 ’25: 2Q1 ’26: 2Q1 ’26filingsflow.com
Total reported value
Q4 ’18: $6.0BQ4 ’18Q1 ’19: $907MQ2 ’19: $1.8BQ2 ’19Q3 ’19: $1.9BQ2 ’21: $1.0BQ2 ’21Q4 ’21: $1.7BQ4 ’22: $156MQ4 ’22Q4 ’25: $8,645Q1 ’26: $4,212Q1 ’26filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
Stanley-Laman Group, Ltd.$814M AUM0.00%$4,09312.0KQ1 2026
Archer Investment Corp$469M AUM0.00%$119350Q1 2026

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.